Mayo recently acquired a minority equity stake in Centerphase Solutions Inc., which is developing ways to speed drug industry-sponsored clinical trials run by major academic research institutions like Mayo. Founded in late 2009 by veterans of Merck Capital Ventures, Centerphase has already raised $2.6 million from investors.